AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,100.00p
   
  • Change Today:
    -266.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,725.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.62m
  • Volume: 222,664
  • Market Cap: £172,119m
  • RiskGrade: 123

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
26-Mar-25 Berenberg Bank Buy 11,232.00p - 140.00p Reiteration
07-Mar-25 Shore Capital Buy 12,072.00p - - Reiteration
19-Feb-25 JP Morgan Cazenove Overweight 11,704.00p - - Reiteration
03-Sep-24 Deutsche Hold 13,190.00p - 11,000.00p Reiteration
02-Jul-24 Jefferies Hold 12,086.00p 71.00p 74.00p Reiteration
28-May-24 Citigroup Buy 12,028.00p - - Reiteration
08-Apr-24 Barclays Overweight 10,610.00p - 12,500.00p Reiteration
12-Feb-24 UBS Sell 9,501.00p 10,700.00p 9,900.00p Reiteration
12-Feb-24 Stifel Buy 9,501.00p 125.00p 120.00p Reiteration
12-Feb-24 BMO Capital Markets Outperform 9,501.00p - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,100.00p
Change Today -266.00p
% Change -2.34 %
52 Week High 13,276.00
52 Week Low 9,725.00
Volume 222,664
Shares Issued 1,550.62m
Market Cap £172,119m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.77% below the market average93.77% below the market average93.77% below the market average93.77% below the market average93.77% below the market average
79.17% below the sector average79.17% below the sector average79.17% below the sector average79.17% below the sector average79.17% below the sector average
Price Trend
37.51% above the market average37.51% above the market average37.51% above the market average37.51% above the market average37.51% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income
67.16% below the market average67.16% below the market average67.16% below the market average67.16% below the market average67.16% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
85.66% above the market average85.66% above the market average85.66% above the market average85.66% above the market average85.66% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 15
Neutral 4
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 02-Apr-2025

Time Volume / Share Price
10:13 1 @ 11,102.00p
10:13 0 @ 11,102.00p
10:13 36 @ 11,100.00p
10:13 0 @ 11,098.00p
10:13 18 @ 11,100.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page